Bio-Kinetic Clinical Applications Report issue

Contributed to NME For profit Phase 1 Phase 2
Founded: Springfield MO United States (1994)
Status: Acquired by QPS (2008)

Organization Overview

First Clinical Trial
2003
NCT00601328
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Bio-Kinetic 1816 W. Mt Vernon, Springfield, MO 65802 | Bio-Kinetic Clincial Applications | Bio-Kinetic Clinical Applications, LLC | BioKinetic Europe | Bio-Kinetic Europe Limited | Bio-Kinetic Europe, Ltd. | Biokinetics | Biokinetics Clinical Applications | Biokinetics, North Irland

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 1)

Arthritis, Rheumatoid (Phase 1)

Aspergillosis (Phase 1)

Chronic Pain (Phase 1)

Clostridium Infections (Phase 1)

Diarrhea (Phase 1)

Dysmenorrhea (Phase 2)

Fecal Incontinence (Phase 1)

Gastroesophageal Reflux (Phase 1)

Osteoarthritis (Phase 1)

Osteoarthritis, Knee (Phase 1)

Osteoporosis (Phase 2)

Premature Ejaculation (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 28
  • # of Trial APIs: 32